CN102258456A - 一种含有抗真菌药物的凝胶剂及其制备方法 - Google Patents
一种含有抗真菌药物的凝胶剂及其制备方法 Download PDFInfo
- Publication number
- CN102258456A CN102258456A CN 201010543365 CN201010543365A CN102258456A CN 102258456 A CN102258456 A CN 102258456A CN 201010543365 CN201010543365 CN 201010543365 CN 201010543365 A CN201010543365 A CN 201010543365A CN 102258456 A CN102258456 A CN 102258456A
- Authority
- CN
- China
- Prior art keywords
- gel
- dissolution
- dissolved
- solvent
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000003429 antifungal agent Substances 0.000 title claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 23
- FJNRUWDGCVDXLU-UHFFFAOYSA-N fenticonazole nitrate Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 FJNRUWDGCVDXLU-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960001337 fenticonazole nitrate Drugs 0.000 claims abstract description 20
- 229920000642 polymer Polymers 0.000 claims abstract description 15
- 230000000857 drug effect Effects 0.000 claims abstract description 10
- 206010017533 Fungal infection Diseases 0.000 claims abstract description 7
- 208000031888 Mycoses Diseases 0.000 claims abstract description 7
- 206010061218 Inflammation Diseases 0.000 claims abstract description 6
- 230000004054 inflammatory process Effects 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 45
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000004090 dissolution Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000005516 engineering process Methods 0.000 claims description 13
- 230000008961 swelling Effects 0.000 claims description 11
- 208000002474 Tinea Diseases 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 241000130764 Tinea Species 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- 229960001631 carbomer Drugs 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 230000003902 lesion Effects 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 208000031636 Body Temperature Changes Diseases 0.000 claims 1
- 206010005908 Body temperature conditions Diseases 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 241001597008 Nomeidae Species 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 235000019437 butane-1,3-diol Nutrition 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 229960004667 ethyl cellulose Drugs 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 229960002900 methylcellulose Drugs 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 abstract description 5
- 230000000007 visual effect Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 241001480043 Arthrodermataceae Species 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 230000037304 dermatophytes Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 22
- 239000000499 gel Substances 0.000 description 21
- 229920001992 poloxamer 407 Polymers 0.000 description 15
- 229940044476 poloxamer 407 Drugs 0.000 description 15
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 14
- 235000010234 sodium benzoate Nutrition 0.000 description 14
- 239000004299 sodium benzoate Substances 0.000 description 14
- 210000001215 vagina Anatomy 0.000 description 8
- 210000004877 mucosa Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229960004756 ethanol Drugs 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- 229920001993 poloxamer 188 Polymers 0.000 description 6
- 229940044519 poloxamer 188 Drugs 0.000 description 6
- 239000000227 bioadhesive Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010007134 Candida infections Diseases 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010067719 Tinea faciei Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 208000005005 intertrigo Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010543365 CN102258456A (zh) | 2010-11-15 | 2010-11-15 | 一种含有抗真菌药物的凝胶剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010543365 CN102258456A (zh) | 2010-11-15 | 2010-11-15 | 一种含有抗真菌药物的凝胶剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102258456A true CN102258456A (zh) | 2011-11-30 |
Family
ID=45005429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010543365 Pending CN102258456A (zh) | 2010-11-15 | 2010-11-15 | 一种含有抗真菌药物的凝胶剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102258456A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104587165A (zh) * | 2015-01-12 | 2015-05-06 | 翔宇药业股份有限公司 | 一种复方硝酸芬替康唑制剂的制备工艺 |
CN108042635A (zh) * | 2018-02-08 | 2018-05-18 | 翔宇药业股份有限公司 | 用于治疗体癣的制剂的制备工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101313904A (zh) * | 2007-06-01 | 2008-12-03 | 北京德众万全药物技术开发有限公司 | 一种用于治疗外阴道炎的芬替康唑栓剂 |
CN101933895A (zh) * | 2009-06-30 | 2011-01-05 | 严洁 | 硝酸芬替康唑的阴道栓剂组合物 |
CN101955462A (zh) * | 2009-07-16 | 2011-01-26 | 邹巧根 | 硝酸芬替康唑和左旋体、右旋体的制备以及左旋体在制备抗真菌药物中的应用 |
-
2010
- 2010-11-15 CN CN 201010543365 patent/CN102258456A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101313904A (zh) * | 2007-06-01 | 2008-12-03 | 北京德众万全药物技术开发有限公司 | 一种用于治疗外阴道炎的芬替康唑栓剂 |
CN101933895A (zh) * | 2009-06-30 | 2011-01-05 | 严洁 | 硝酸芬替康唑的阴道栓剂组合物 |
CN101955462A (zh) * | 2009-07-16 | 2011-01-26 | 邹巧根 | 硝酸芬替康唑和左旋体、右旋体的制备以及左旋体在制备抗真菌药物中的应用 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104587165A (zh) * | 2015-01-12 | 2015-05-06 | 翔宇药业股份有限公司 | 一种复方硝酸芬替康唑制剂的制备工艺 |
CN108042635A (zh) * | 2018-02-08 | 2018-05-18 | 翔宇药业股份有限公司 | 用于治疗体癣的制剂的制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0785770B1 (en) | Hemorrhoidal compositions and method of use | |
US11458190B2 (en) | Mussel adhesive protein product and use thereof for treating mucosal inflammation | |
JP2002524408A (ja) | 性的機能不全を治療するための製剤 | |
CN101919807B (zh) | 栓剂组合物 | |
CN108635585A (zh) | 一种治疗老年性阴道炎的药物组合物及温敏缓释凝胶剂和制备方法 | |
CN102379879B (zh) | 一种含有利拉萘酯和糠酸莫米松的局部应用复方药物组合物 | |
Sharma et al. | Once daily bioadhesive vaginal clotrimazole tablets: Design and evaluation | |
CN102258456A (zh) | 一种含有抗真菌药物的凝胶剂及其制备方法 | |
KR20150036091A (ko) | 올리고머 락트산을 포함하는 약제학적 조성물 | |
CN103751098B (zh) | 重组人干扰素α2а阴道膨胀栓及其制备方法和检测方法 | |
Gupta et al. | Intravaginal delivery approaches for contraception: an overview with emphasis on gels | |
CN103251550A (zh) | 含有秋水仙碱的透皮给药膏剂及其制备方法 | |
JP5979466B2 (ja) | 粘性液組成物 | |
CN1167446C (zh) | 一种治疗宫颈炎及宫颈糜烂的中药凝胶剂及制备方法 | |
US20200093858A1 (en) | Vaginal bioadhesive boric acid formulation and its preparation method | |
CN113712904B (zh) | 一种布地奈德柔性脂质体温敏凝胶及其制备方法 | |
CN104606212A (zh) | 一种避孕及杀微生物双功能阴道复合温敏水凝胶制剂及其制备方法 | |
CN103271984B (zh) | 一种治疗溃疡性结肠炎与妇科炎症的苦豆子总碱温敏凝胶剂的制备方法及其应用 | |
CN102100683B (zh) | 一种缓溶性外用避孕膜 | |
Rakasiwi et al. | Development of Drug Delivery System for Sinus Mucosal Tissues with Mucoadhesive Thermosensitive Sol-Gel Components: Analysis of Evidence from Laboratory to Animal Research | |
CN115887357A (zh) | 氨苯砜凝胶制剂及其制备方法 | |
CN115025209A (zh) | 一种含溶菌酶的私护凝胶 | |
EP4282417A1 (en) | Association of tadalafil and vitamin d3 for use in the oral treatment of benign prostatic hypertrophy and production methods thereof | |
TWI324930B (en) | Prostaglandin compositions and methods of treatment for male erectile dysfunction | |
CN117860670A (zh) | 一种千层纸素外用制剂及其在银屑病治疗上的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DD01 | Delivery of document by public notice |
Addressee: Zou Qiaogen Document name: Notification to Make Rectification |
|
C06 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Zou Qiaogen Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Nanjing Tech University Applicant after: Zou Qiaogen Address before: 8, building 26, 210009 Ma Jia street, Gulou District, Nanjing, Jiangsu Applicant before: Zou Qiaogen |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: NANJING HEALTHNICE MEDICAL TECHNOLOGY Co.,Ltd. Assignor: Zou Qiaogen Contract record no.: 2012320000065 Denomination of invention: Gel containing antifungal drug and preparation method thereof License type: Exclusive License Open date: 20111130 Record date: 20120209 |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111130 |